A Delaware jury has sided with Globus Medical (NYSE:GMED), issuing a verdict in favor of the orthopedic product maker in a patent infringement case against its rival Life Spine over the latter’s Prolift family of implants.
Welcome to AI Investor Picks, your trusted source for investment insights, financial strategies, and business opportunities. We are dedicated to providing cutting-edge information and analysis on a wide range of investment topics, including stocks, cryptocurrency, real estate, finance, and much more.
